Results 41 to 50 of about 1,964,998 (260)

Bayexer: an accurate and fast Bayesian demultiplexer for Illumina sequences [PDF]

open access: yesBioinformatics, 2015
Abstract Summary: Demultiplexing is used after high-throughput sequencing to in silico assign reads to the samples of origin based on the sequenced reads of the indices. Existing demultiplexing tools based on the similarity between the read index and the reference index sequences may fail to provide satisfactory results on low-quality ...
Haisi Yi, Zhe Li, Tao Li, Jindong Zhao
openaire   +2 more sources

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Reliable variant calling during runtime of Illumina sequencing [PDF]

open access: yesScientific Reports, 2018
Abstract The sequential paradigm of data acquisition and analysis in next-generation sequencing leads to high turnaround times for the generation of interpretable results. We combined a novel real-time read mapping algorithm with fast variant calling to obtain reliable variant calls still during the sequencing process.
Loka, Tobias P.   +2 more
openaire   +2 more sources

Illumina-corrected Pacific Biosciences long-read data

open access: yes, 2013
FASTA of Pacific Biosciences subreads of file 17618_filtered_subreads.fasta.gz after correction by Agave tequilana Illumina data.
Abraham-Juarez, María Jazmín   +11 more
core   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Illumina MiSeq raw sequence reads from arbuscular mycorrhizal fungi of grapevine and rye roots

open access: yes, 2021
Illumina MiSeq raw sequence reads of the partial LSU region of the rDNA gene obtained from grapevine and rye root mycorrhizal ...
Nogales, A
core   +2 more sources

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

VADER PylT Illumina sequencing data

open access: yes, 2022
FASTQ files used in data analysis for "Virus-assisted directed evolution of enhanced suppressor tRNAs in mammalian cells."
openaire   +2 more sources

Summary of the sequence assembly after Illumina sequencing.

open access: yes, 2014
Summary of the sequence assembly after Illumina sequencing.
Suyan Niu (488130)   +5 more
core   +1 more source

APOBEC3 activity and DNA polymerase‐ε deficiency are associated with distinct IDH1 R132 hotspot mutations

open access: yesMolecular Oncology, EarlyView.
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy